Modern Diagnostic & Research Centre Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹15(16.67%)
Premium (ELP)
Modern Diagnostic & Research Centre Limited's successfully completed its Initial Public Offering and commenced trading on Jan 07, 2026 at the BSE exchange. The company raised 40,99,200 Shares through this public offering, comprising 40,99,200 Shares in fresh capital.
The IPO was priced within the band of ₹85 to ₹90, with minimum application lots of 1600 shares. The offering attracted significant investor interest during its subscription period from Dec 31, 2025 to Jan 02, 2026.
Share allotment was finalized on Jan 05, 2026, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 1985, Modern Diagnostic & Research Centre Limited is an India-based diagnostic service provider offering a wide range of pathology and radiology services to patients and institutions. The company delivers reliable diagnostic testing along with home sample collection, online report access, and customized health packages designed to meet individual and institutional requirements. It operates 21 centres, including 17 laboratories and 4 diagnostic centres, spread across 8 states, and provides services such as ultrasound, CT scan, MRI, X-ray, ECG, PFT, and specialized diagnostic facilities for cardiac and neurological care. Its pathology services cover routine tests as well as advanced molecular diagnostics, cytogenetics, and specialized testing for genetic disorders and cancer, while radiology services include MRI, CT scans, ultrasound, and digital X-rays using modern equipment. As of February 28, 2025, the company has a workforce of 570 employees, including doctors and consultants.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Wide diagnostic service portfolio: Offers comprehensive pathology and radiology services, including advanced imaging and specialised tests for cardiac, neurological, genetic, and cancer diagnostics.
- Strong operational network: Operates 21 centres across 8 states, enabling wider reach and improved accessibility for patients and institutional clients.
- Experienced medical workforce: Backed by qualified doctors, consultants, and technical staff, ensuring reliable testing, accurate reports, and consistent service quality.
- High capital investment requirement: Continuous spending is needed for advanced diagnostic equipment, technology upgrades, and maintenance.
- Regulatory and compliance dependence: Operations are subject to healthcare regulations, accreditations, and quality standards, which can increase operational complexity and costs.
- Intense industry competition: Faces strong competition from large national diagnostic chains and local players, which may impact pricing power and profit margins.
- Mr. Devendra Singh Yadav
- Mrs. Deepali Yadav
- Mrs. Asha Yadav
- Mr. Jitendra Singh
Modern Diagnostic & Research Centre Limited
Link Intime India Private Limited